Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Interventional Cardiology Market, by Type
1.1.2. Global Interventional Cardiology Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution and Sales
5.2.4. Post Sales Services
6. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE
6.1. Overview
6.2. Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Drug Eluting Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Bare Metal Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3. Bioresorbable Vascular Scaffolds
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. PTCA Catheters
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.1. Balloon Catheters
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.2. Guiding Catheters
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Plaque Modification Devices
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Coronary Guidewires
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6. Accessories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY END USER
7.1. Overview
7.2. Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Cardiac Catheterization Laboratories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY REGION
8.1. Overview
8.2. Americas
8.2.1. North America
8.2.1.1. US
8.2.1.2. Canada
8.2.2. Latin America
8.3. Europe
8.3.1. Western Europe
8.3.1.1. Germany
8.3.1.2. France
8.3.1.3. Italy
8.3.1.4. Spain
8.3.1.5. UK
8.3.1.6. Rest of Western Europe
8.3.2. Eastern Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
9. COMPANY LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Company Share Analysis
9.4. Competitor Dashboard
9.5. Major Growth Strategy in the Global Interventional Cardiology Market
9.6. Competitive Benchmarking
9.7. Leading Player in terms of Number of Developments in the Global Interventional Cardiology Market
9.8. Key Developments & Growth Strategies
9.8.1. New Product Launch
9.8.2. Merger & Acquisition
9.8.3. Joint Ventures
9.9. Major Players Financial Matrix & Market Ratio
9.9.1. Sales & Operating Income 2020
9.9.2. Major Players R&D Expenditure 2020
9.9.3. Major Players Capital Market Ratio
10. COMPANY PROFILES
10.1. ABIOMED
10.1.1. Company Overview
10.1.2. Products/Services Offered
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Abbott
10.3. ACIST Medical Systems, Inc.
10.4. B. Braun Melsungen AG
10.5. BD
10.6. Biosense Webster, Inc
10.7. Biotronik SE & Co. KG
10.8. Boston Scientific Corporation
10.9. Cardinal Health
10.10. Cook Medical
10.11. Edwards Lifesciences Corporation
10.12. GE Healthcare
10.13. Koninklijke Philips N.V.
10.14. Life Vascular Devices Biotech S.L.
10.15. Medtronic
10.16. Merit Medical Systems, Inc
10.17. Terumo Corporation
10.18. W. L. Gore & Associates, Inc.
10.19. Others
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 6 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 8 US: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 9 US: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 10 CANADA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 11 CANADA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 12 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 13 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 14 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 15 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 16 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 17 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 18 EASTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 19 EASTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET
FIGURE 4 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY END USER, 2020 (%)
FIGURE 6 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 AMERICAS: INTERVENTIONAL CARDIOLOGY MARKET SHARE BY REGION, 2020 (%)
FIGURE 8 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 9 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 11 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 14 ABIOMED: KEY FINANCIALS
FIGURE 15 ABIOMED: SEGMENTAL REVENUE
FIGURE 16 ABIOMED: REGIONAL REVENUE
FIGURE 17 ABBOTT: KEY FINANCIALS
FIGURE 18 ABBOTT: SEGMENTAL REVENUE
FIGURE 19 ABBOTT: REGIONAL REVENUE
FIGURE 20 ACIST MEDICAL SYSTEMS, INC.: KEY FINANCIALS
FIGURE 21 ACIST MEDICAL SYSTEMS, INC.: SEGMENTAL REVENUE
FIGURE 22 ACIST MEDICAL SYSTEMS, INC.: REGIONAL REVENUE
FIGURE 23 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 24 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 25 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
FIGURE 26 BD: KEY FINANCIALS
FIGURE 27 BD: SEGMENTAL REVENUE
FIGURE 28 BD: REGIONAL REVENUE
FIGURE 29 BIOSENSE WEBSTER, INC: KEY FINANCIALS
FIGURE 30 BIOSENSE WEBSTER, INC: SEGMENTAL REVENUE
FIGURE 31 BIOSENSE WEBSTER, INC: REGIONAL REVENUE
FIGURE 32 BIOTRONIK SE & CO. KG: KEY FINANCIALS
FIGURE 33 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE
FIGURE 34 BIOTRONIK SE & CO. KG: REGIONAL REVENUE
FIGURE 35 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS
FIGURE 36 BOSTON SCIENTIFIC CORPORATION.: SEGMENTAL REVENUE
FIGURE 37 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE
FIGURE 38 CARDINAL HEALTH: KEY FINANCIALS
FIGURE 39 CARDINAL HEALTH: SEGMENTAL REVENUE
FIGURE 40 CARDINAL HEALTH: REGIONAL REVENUE
FIGURE 41 COOK MEDICAL: KEY FINANCIALS
FIGURE 42 COOK MEDICAL: SEGMENTAL REVENUE
FIGURE 43 COOK MEDICAL: REGIONAL REVENUE
FIGURE 44 EDWARDS LIFESCIENCES CORPORATION: KEY FINANCIALS
FIGURE 45 EDWARDS LIFESCIENCES CORPORATION: SEGMENTAL REVENUE
FIGURE 46 EDWARDS LIFESCIENCES CORPORATION: REGIONAL REVENUE
FIGURE 47 GE HEALTHCARE: KEY FINANCIALS
FIGURE 48 GE HEALTHCARE: SEGMENTAL REVENUE
FIGURE 49 GE HEALTHCARE: REGIONAL REVENUE
FIGURE 50 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS
FIGURE 51 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE
FIGURE 52 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE
FIGURE 53 LIFE VASCULAR DEVICES BIOTECH S.L.: KEY FINANCIALS
FIGURE 54 LIFE VASCULAR DEVICES BIOTECH S.L.: SEGMENTAL REVENUE
FIGURE 55 LIFE VASCULAR DEVICES BIOTECH S.L.: REGIONAL REVENUE
FIGURE 56 MEDTRONIC: KEY FINANCIALS
FIGURE 57 MEDTRONIC: SEGMENTAL REVENUE
FIGURE 58 MEDTRONIC: REGIONAL REVENUE
FIGURE 59 MERIT MEDICAL SYSTEMS, INC: KEY FINANCIALS
FIGURE 60 MERIT MEDICAL SYSTEMS, INC: SEGMENTAL REVENUE
FIGURE 61 MERIT MEDICAL SYSTEMS, INC: REGIONAL REVENUE
FIGURE 62 TERUMO CORPORATION: KEY FINANCIALS
FIGURE 63 TERUMO CORPORATION: SEGMENTAL REVENUE
FIGURE 64 TERUMO CORPORATION: REGIONAL REVENUE
FIGURE 65 W. L. GORE & ASSOCIATES, INC.: KEY FINANCIALS
FIGURE 66 W. L. GORE & ASSOCIATES, INC.: SEGMENTAL REVENUE
FIGURE 67 W. L. GORE & ASSOCIATES, INC.: REGIONAL REVENUE
